Published in Health Risk Factor Week, November 14th, 2006
Study 1: Implantable cardioverter defibrillator recipients with renal insufficiency have a significantly higher mortality rate.
"Patients with renal insufficiency have an increased risk of atherosclerotic coronary artery disease, cardiovascular events, and sudden cardiac death. Due to under-representation of patients with renal disease in large clinical trials, outcomes of implantable cardioverter defibrillator (ICD) implantation in this group remain unclear. Inpatient and ambulatory records were reviewed for 741 consecutive patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.